Back to Trades
Kelly Jared
Chief Executive OfficerDirectorCIK 0002103581
Profile
- Filings
- 3
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Kelly Jared, Chief Executive Officer, Director, has filed 3 SEC reports (2026), all concentrated in ONCOLYTICS BIOTECH INC (ONCY), totaling $34.4K in disclosed volume. Weighing $34.4K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $29.5K in ONCOLYTICS BIOTECH INC. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jun 3 | ONCY ONCOLYTICS BIOTECH INC | Kelly Jared | Chief Executive Officer, Director | Award | $0 |
| Mar 13 | ONCY ONCOLYTICS BIOTECH INC | Kelly Jared | Chief Executive Officer, Director | Buy | $4.8K |
| Feb 13 | ONCY ONCOLYTICS BIOTECH INC | Kelly Jared | Chief Executive Officer, Director | Buy | $29.5K |
3 filings